74
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT

, , , , , , , & show all
Pages 479-491 | Published online: 26 Feb 2019

References

  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease2018 Available from: https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdfAccessed October 11, 2018
  • HillasGPerlikosFTsiligianniITzanakisNManaging comorbidities in COPDInt J Chron Obstruct Pulmon Dis2015109510925609943
  • JenkinsCRChapmanKRDonohueJFRocheNTsiligianniIHanMKImproving the management of COPD in womenChest2017151368669627816445
  • SinghDRocheNHalpinDAgustiAWedzichaJAMartinezFJCurrent controversies in the pharmacological treatment of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2016194554154927585383
  • GodtfredsenNSLamTHHanselTTCOPD-related morbidity and mortality after smoking cessation: status of the evidenceEur Respir J200832484485318827152
  • AnthonisenNRConnettJEKileyJPEffects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health StudyJAMA199427219149715057966841
  • ScanlonPDConnettJEWallerLASmoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease, The Lung Health StudyAm J Respir Crit Care Med20001612 Pt 138139010673175
  • MahlerDADecramerMD’UrzoADual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE studyEur Respir J20144361599160924176997
  • SinghDFergusonGTBolitschekJTiotropium + olodaterol shows clinically meaningful improvements in quality of lifeRespir Med2015109101312131926320402
  • SinghDJonesPWBatemanEDEfficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised studyBMC Pulm Med201414117825404569
  • D’UrzoADRennardSIKerwinEMEfficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD studyRespir Res201415112325756831
  • BatemanEDChapmanKRSinghDAclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multi-centre, randomised studies (ACLIFORM and AUGMENT)Respir Res2015169226233481
  • di MarcoFSantusPScichiloneNSymptom variability and control in COPD: advantages of dual bronchodilation therapyRespir Med2017125495628340862
  • European Medicines AgencyDuaklir® Genuair™ (aclidinium bromide/formoterol fumarate dihydrate)2014 Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003745/human_med_001811jsp&mid=WC0b01ac058001d124Accessed November 07, 2017
  • HanMKPostmaDManninoDMGender and chronic obstructive pulmonary disease: why it mattersAm J Respir Crit Care Med2007176121179118417673696
  • AryalSDiaz-GuzmanEManninoDMInfluence of sex on chronic obstructive pulmonary disease risk and treatment outcomesInt J Chron Obstruct Pulmon Dis201491145115425342899
  • KannerREConnettJEAltoseMDGender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health StudyAm J Respir Crit Care Med199415049569617921469
  • SorianoJBSinDDZhangXA pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placeboChest2007131368268917356080
  • TashkinDPAltoseMDConnettJEKannerRELeeWWWiseRAMethacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study. Research GroupAm J Respir Crit Care Med19961536 Pt 1180218118665038
  • TashkinDCelliBKestenSLystigTDecramerMEffect of tiotropium in men and women with COPD: results of the 4-year UPLIFT trialRespir Med2010104101495150420418083
  • MiravitllesMChapmanKRChuecosFRiberaAGarcia GilEThe efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysisInt J Chron Obstruct Pulmon Dis2016112041205327621610
  • RileyJKrügerPOptimising inhaler technique in chronic obstructive pulmonary disease: a complex issueBr J Nurs201726739139728410043
  • BarbaraSKritikosVBosnic-AnticevichSInhaler technique: does age matter? A systematic reviewEur Respir Rev20172614617005529212836
  • dal NegroRWDry powder inhalers and the right things to remember: a concept reviewMultidiscip Respir Med20151011325878791
  • MolimardMRaherisonCLignotSChronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patientsEur Respir J2017492160179428182569
  • UsmaniOSLavoriniFMarshallJCritical inhaler errors in asthma and COPD: a systematic review of impact on health outcomesRespir Res20181911029338792
  • D’UrzoASinghDGarcia GilEUse of concomitant inhaled corticosteroids: pooled data from two phase III studies of aclidinium plus formoterol in COPDNPJ Prim Care Respir Med20172711328235977